Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

416 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.
Smolen JS, Landewé RBM, Bijlsma JWJ, Burmester GR, Dougados M, Kerschbaumer A, McInnes IB, Sepriano A, van Vollenhoven RF, de Wit M, Aletaha D, Aringer M, Askling J, Balsa A, Boers M, den Broeder AA, Buch MH, Buttgereit F, Caporali R, Cardiel MH, De Cock D, Codreanu C, Cutolo M, Edwards CJ, van Eijk-Hustings Y, Emery P, Finckh A, Gossec L, Gottenberg JE, Hetland ML, Huizinga TWJ, Koloumas M, Li Z, Mariette X, Müller-Ladner U, Mysler EF, da Silva JAP, Poór G, Pope JE, Rubbert-Roth A, Ruyssen-Witrand A, Saag KG, Strangfeld A, Takeuchi T, Voshaar M, Westhovens R, van der Heijde D. Smolen JS, et al. Among authors: bijlsma jwj. Ann Rheum Dis. 2020 Jun;79(6):685-699. doi: 10.1136/annrheumdis-2019-216655. Epub 2020 Jan 22. Ann Rheum Dis. 2020. PMID: 31969328 Free article.
Altered neuroendocrine immune (NEI) networks in rheumatology.
Cutolo M, Bijlsma JW, Lahita RG, Masi AT, Straub RH, Bradlow HL. Cutolo M, et al. Ann N Y Acad Sci. 2002 Jun;966:xiii-xviii. doi: 10.1111/j.1749-6632.2002.tb04195.x. Ann N Y Acad Sci. 2002. PMID: 12114252 Review. No abstract available.
Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year.
Verstappen SM, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, Borg EJ, Hofman DM, van der Veen MJ; Utrecht Arthritis Cohort Study Group. Verstappen SM, et al. Arthritis Rheum. 2003 Jul;48(7):1797-807. doi: 10.1002/art.11170. Arthritis Rheum. 2003. PMID: 12847672 Free article. Clinical Trial.
Developments in glucocorticoid therapy.
Bijlsma JW, Saag KG, Buttgereit F, da Silva JA. Bijlsma JW, et al. Rheum Dis Clin North Am. 2005 Feb;31(1):1-17, vii. doi: 10.1016/j.rdc.2004.10.003. Rheum Dis Clin North Am. 2005. PMID: 15639052 Review.
Neuroendocrine immune system involvement in rheumatology.
Bijlsma JW, Masi A, Straub RH, Lahita R, Cutolo M. Bijlsma JW, et al. Ann N Y Acad Sci. 2006 Jun;1069:xviii-xxiv. doi: 10.1196/annals.1351.049. Ann N Y Acad Sci. 2006. PMID: 16883655 No abstract available.
416 results